2 employees
Sisu Pharma is developing drugs against a new target to treat prostate cancer.
2019
$1.7M
from 1 investors over 1 rounds
Sisu Pharma raised $1.7M on October 19, 2020
Investors: Viva Ventures Biotech Fund